Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Cdk5 Inhibitors

Cdk5 inhibitors belong to a class of chemical compounds designed to target and inhibit the activity of cyclin-dependent kinase 5 (Cdk5), an enzyme crucial for regulating cell cycle progression and neuronal development. Cdk5 is a member of the cyclin-dependent kinase family, which plays a central role in governing cell cycle transitions and cellular processes such as transcription, metabolism, and differentiation. Cdk5, while originally identified for its role in neuronal development, has been found to have broader implications in various cellular functions. As a consequence, researchers have explored the development of inhibitors that can modulate its activity. Cdk5 inhibitors are designed with the intention of selectively binding to the active site of the Cdk5 enzyme, thereby preventing its interaction with specific cyclin partners and impairing its ability to phosphorylate target proteins. By disrupting these phosphorylation events, Cdk5 inhibitors can influence cellular processes that rely on proper protein phosphorylation, including signal transduction pathways and gene expression. Structurally diverse, these inhibitors are tailored to fit the active site of Cdk5, aiming to achieve high specificity and affinity for the target enzyme. Researchers have investigated various chemical scaffolds and modifications to optimize binding interactions and inhibitory potency. In conclusion, Cdk5 inhibitors represent a significant category of chemical compounds that hold promise for modulating cellular processes reliant on Cdk5 activity. By selectively interfering with the enzyme's function, these inhibitors contribute to a deeper understanding of the complex regulatory networks in which Cdk5 participates.

SEE ALSO...

Items 21 to 30 of 39 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cdc2-Like Kinase Inhibitor, TG003

300801-52-9sc-202528
sc-202528A
5 mg
25 mg
$139.00
$548.00
6
(0)

TG003 blocks CDK5 activity by binding to the ATP-binding pocket, preventing the enzyme from phosphorylating its substrates.

Butyrolactone I

87414-49-1sc-201533
sc-201533A
200 µg
1 mg
$122.00
$514.00
1
(0)

Butyrolactone I functions as a CDK5 inhibitor by disrupting the interaction between CDK5 and its activator, p35.

Hymenidin

107019-95-4sc-202177
1 mg
$263.00
(0)

Hymenidin (CAS 107019-95-4) acts as a Cdk5 inhibitor, influencing vital cellular processes associated with this enzyme. Its inhibitory function in relation to Cdk5 has broad effects on various cellular activities.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

Y-27632 acts as a CDK5 inhibitor by suppressing the kinase activity through competitive inhibition at the ATP-binding site.

N9-Isopropyl-olomoucine

158982-15-1sc-202264
sc-202264A
1 mg
5 mg
$181.00
$650.00
1
(0)

N9-Isopropyl-olomoucine (CAS 158982-15-1) functions as a Cdk5 inhibitor, modulating essential cellular processes associated with this enzyme. Its inhibitory role in relation to Cdk5 has significant effects on various cellular activities.

CR8, (R)-Isomer

294646-77-8sc-311306
5 mg
$174.00
(0)

CR8, (R)-Isomer (CAS 294646-77-8) acts as a Cdk5 inhibitor, influencing crucial cellular processes associated with this enzyme. Its inhibitory function in relation to Cdk5 has diverse effects on various cellular activities.

Indirubin-3′-monoxime-5-sulphonic Acid

331467-05-1sc-221753
1 mg
$187.00
1
(0)

Indirubin-3'-monoxime-5-sulphonic Acid acts as a Cdk5 modulator through its ability to form hydrogen bonds and hydrophobic interactions with key residues in the enzyme's active site. This compound's structural features promote a conformational shift in Cdk5, which can alter its catalytic efficiency. The sulfonic acid moiety enhances aqueous solubility, allowing for improved accessibility to the enzyme, thereby influencing reaction kinetics and cellular signaling cascades.

Cdk4/6 Inhibitor IV

359886-84-3sc-203874
5 mg
$265.00
3
(1)

Cdk4/6 Inhibitor IV exhibits unique interactions with Cdk5 by stabilizing its inactive conformation through specific electrostatic interactions and steric hindrance. This compound's distinct structural motifs facilitate selective binding, effectively modulating the enzyme's activity. Its ability to disrupt critical phosphorylation pathways highlights its role in regulating cellular processes, while its lipophilic characteristics may influence membrane permeability and localization within cellular compartments.

Aloisine A

496864-16-5sc-202451
1 mg
$62.00
(0)

Aloisine A demonstrates a remarkable ability to selectively inhibit Cdk5 through intricate molecular interactions that involve hydrogen bonding and hydrophobic contacts. This compound alters the enzyme's conformational dynamics, leading to a decrease in its kinase activity. Its unique structural features allow for specific recognition of Cdk5, impacting downstream signaling pathways. Additionally, its solubility properties may affect its distribution and interaction with cellular targets, enhancing its regulatory potential.

GSK-3 Inhibitor IX, Control, MeBIO

710323-61-8sc-221688
1 mg
$135.00
(1)

GSK-3 Inhibitor IX, Control, MeBIO exhibits a distinctive mechanism of action by modulating the phosphorylation state of substrates through its interaction with Cdk5. This compound engages in specific electrostatic interactions that stabilize the enzyme-substrate complex, influencing reaction kinetics. Its unique steric configuration facilitates selective binding, potentially altering the enzyme's catalytic efficiency. Furthermore, its lipophilic characteristics may enhance membrane permeability, impacting cellular localization and interaction dynamics.